Yaribeygi, H., Maleki, M., Reiner, Ž., Jamialahmadi, T. i Sahebkar, A. (2022). Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu. Journal of Clinical Medicine, 11. (21). doi: 10.3390/jcm11216544
Yaribeygi, Habib, et al. "Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu." Journal of Clinical Medicine, vol. 11, br. 21, 2022. https://doi.org/10.3390/jcm11216544
Yaribeygi, Habib, Mina Maleki, Željko Reiner, Tannaz Jamialahmadi i Amirhossein Sahebkar. "Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu." Journal of Clinical Medicine 11, br. 21 (2022). https://doi.org/10.3390/jcm11216544
Yaribeygi, H., et al. (2022) 'Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu', Journal of Clinical Medicine, 11(21). doi: 10.3390/jcm11216544
Yaribeygi H, Maleki M, Reiner Ž, Jamialahmadi T, Sahebkar A. Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu. Journal of Clinical Medicine [Internet]. 04.11.2022. [pristupljeno 22.08.2024.];11(21). doi: 10.3390/jcm11216544
H. Yaribeygi, M. Maleki, Ž. Reiner, T. Jamialahmadi i A. Sahebkar, "Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu", Journal of Clinical Medicine, vol. 11, br. 21, Studeni 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:843634. [Citirano: 22.08.2024.]